Artificial Pancreas Device System Market Analysis, Size, Growth, Share, Outlook & Forecast to 2024 | Grand View Research Inc.
The global artificial pancreas device system market is anticipated to reach USD 390.4 million by 2024, according to a new report by Grand View Research, Inc. Increasing prevalence of diabetes, intensive R&D efforts by industry players, and rising demand for automated systems for glycemic control are the key factors that are driving the market growth. Regulatory bodies such as FDA are continuously approving new and innovative products which is increasing the reach of the companies in various market. For instance, in December 2016, OneTouch Vibe plus Insulin Pump by Animas received FDA approval and Health Canada License for the sale of the product. In January 2016, Animas received FDA approval for Animas Vibe Insulin Pump, the device to manage of diabetes in children and adolescents. Similarly, in June 2016, Tandem Diabetes Care cleared its FDA approval for remote software update tool for insulin pump. Also, in September 2016, the company received FDA approval for their product t:slim G4 Insulin Pump giving the diabetes community a powerful new tool to help simplify therapy managementSuch factors are contributing to the growth of the market. Further Key Findings From the Study Suggest:
Control to Target (CTT) systems is anticipated to witness fastest growth during the forecast period as they are fully automated and require no intervention on the patient’s part for the administration of insulin or for the monitoring of glucose levels.
Asia Pacific artificial pancreas device system market is expected to grow with the highest CAGR over the forecast period owing to the lifestyle, genetic modification, urbanization and aging population.
Major players of the market include, Medtronic Plc, Bigfoot Biomedical, Johnson & Johnson, Tandem Diabetes Care, Inc., Pancreum, Inc., TypeZero Technologies, LLC, and Beta Bionics.
Browse Details of Report @ https://www.grandviewresearch.com/industry-analysis/artificialpancreas-device-market
Grand View Research has segmented the global artificial pancreas device system market on the basis of device type and region: Artificial Pancreas Device System Device Type Outlook (Revenue, USD Million, 2013 - 2024)
Threshold suspended device system
CTR System
CTT System
Artificial Pancreas Device System Regional Outlook (Revenue, USD Million, 2013 - 2024)
North America o
U.S.
o
Canada
Europe
o
Germany
o
UK
Asia Pacific o
Japan
o
China
Latin America o
Brazil
o
Mexico
Middle East and Africa (MEA) o
South Africa
Get Sample of Report @ https://www.grandviewresearch.com/industry-analysis/artificial-pancreasdevice-market/request/rs1
Table of Content
Chapter 1 Research Methodology 1.1 Research Methodology 1.2 Research Scope & Assumptions 1.3 List of Data Sources Chapter 2 Executive Summary Chapter 3 Market Summary Chapter 4 Market Variables, Trends & Scope
4.1 Market Segmentation & Scope 4.2 Market Driver Analysis 4.3 Market Restraint Analysis 4.4 Penetration & Growth Prospect Mapping 4.5 SWOT Analysis, By Factor 4.5.1 Political 4.5.2 Economic 4.5.3 Technology Chapter 5 Market Categorization 1: Device Type Estimates & Trend Analysis 5.1 Device Type Movement Analysis & Market Share, 2015 & 2024 5.2 Market Size & Forecasts and Trend Analyses, 2013 to 2024 for the following device types: 5.2.1 Threshold suspended device system Continue‌‌‌ About Grand View Research, Inc.: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: sales@grandviewresearch.com For More Information: http://www.grandviewresearch.com